Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer

Clinical trial NCT02626130 · COMPLETED

Trial details

NCT number: NCT02626130
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Metastatic Renal Cell Cancer Stage IV Renal Cell Cancer AJCC v7

Start date: 2016-03-30
Primary completion: 2022-06-20
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.